Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

Lung Therapeutics, Inc. Raises $36 Million in Series C Financing

HUGE congrats to member company, Lung Therapeutics, on their $36 Million Series C financing to advance their clinical pipeline. Lung Therapeutics has been a member of ACC Bioscience Incubator since January 2018 and we are so proud of their success. Read more via Yahoo...
EQO wins MassChallenge TX $100K Diamond Award!

EQO wins MassChallenge TX $100K Diamond Award!

ACC Bioscience Incubator member company, Environmental Quality Operations (EQO), won the $100,000 Diamond Award from MassChallenge TX as part of the accelerator’s inaugural cohort. This was MassChallenge TX’s top prize, with EQO being selected out of...